Found 11 bookmarks
Custom sorting
Let's discuss why the idea that Sc2 causes cancer is not far-fetched, how waiting until we have definitive answers on this topic is a bad idea for us personally, and why (and what) Public Health worldwide needs to do better. (4/)
Let's discuss why the idea that Sc2 causes cancer is not far-fetched, how waiting until we have definitive answers on this topic is a bad idea for us personally, and why (and what) Public Health worldwide needs to do better. (4/)
“Let's discuss why the idea that Sc2 causes cancer is not far-fetched, how waiting until we have definitive answers on this topic is a bad idea for us personally, and why (and what) Public Health worldwide needs to do better. (4/)”
·x.com·
Let's discuss why the idea that Sc2 causes cancer is not far-fetched, how waiting until we have definitive answers on this topic is a bad idea for us personally, and why (and what) Public Health worldwide needs to do better. (4/)
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
“..:Patel and other concerned scientists are calling on the U.S. government to make this question [of whether Covid is causing rise in cancer] a priority knowing it could affect treatment and management of millions of cancer patients for decades to come.”
·apple.news·
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Via WaPo: “I’ve been in practice 23 years and have never seen anything like this,” oncologist Kashyap Patel said.
Via WaPo: “I’ve been in practice 23 years and have never seen anything like this,” oncologist Kashyap Patel said.

“‘I’ve been in practice 23 years and have never seen anything like this,’ oncologist Kashyap Patel said.

Asutosh Gor, another oncologist, agreed: ‘We were all shaken.’

There was other weirdness, too: multiple patients contending w multiple types of cancer arising almost simultaneously, and more than a dozen new cases of other rare cancers…. The uptick in aggressive, late-stage cancers since the…pandemic is confirmed by early national data and a number of large cancer institutions.

Many…dismissed the trend as a consequence of disruptions to health care that began in 2020.

But not everyone.

The idea that some viruses can cause or accelerate cancer is hardly new… 15 to 20 percent of all cancers worldwide originate from infectious agents…”

·x.com·
Via WaPo: “I’ve been in practice 23 years and have never seen anything like this,” oncologist Kashyap Patel said.
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways - Cell Communication and Signaling
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways - Cell Communication and Signaling

“The correlation of COVID-19 and cancer poses significant challenges, as cancer patients are immunocompromised and more susceptible to viral infections. This dual burden has spurred extensive research to understand the correlation between the two diseases and to develop suitable therapeutic strategies. Reports have shown that SARS-CoV-2 proteins, such as the M protein, non-structural proteins, and spike protein, influence cellular functions relevant to cancer progression. These proteins can inhibit tumor suppressor genes, activate survival signaling pathways, stimulate cytokine production, and activate the NF-κB pathway, creating a tumorigenic environment. Additionally, SARS-CoV-2 proteins can promote metastasis by upregulating mesenchymal markers and metastasis-related signaling pathways. They have the ability to alter metabolic pathways, cause damage to DNA, and inhibit DNA repair systems, which can result in genomic instability and metabolic reprogramming that are specific to cancer cells. These viral proteins also influence programmed cell death evasion and aid immune evasion through upregulation of PD-L1 and M2 macrophage polarization. COVID-19 is further linked with epigenetic modifications induced by SARS-CoV-2, such as DNA methylation and histone deacetylation, that further may lead to changes in gene expression associated with cancer development. The activation of NLRP3 inflammasomes by SARS-CoV-2 intersects with multiple cancer hallmarks, suggesting a role in cancer development and progression.”

·biosignaling.biomedcentral.com·
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways - Cell Communication and Signaling
A close relative was diagnosed with a rare T cell lymphoma called Mycosis fungoides today. I wish I could adequately describe how many people I know with rare cancers at the moment.
A close relative was diagnosed with a rare T cell lymphoma called Mycosis fungoides today. I wish I could adequately describe how many people I know with rare cancers at the moment.

A close relative was diagnosed with a rare T cell lymphoma called Mycosis fungoides today. I wish I could adequately describe how many people I know with rare cancers at the moment.

I WHOLEHEARTEDLY believe—no, I KNOW—it’s a result of Covid.

A thread:

·x.com·
A close relative was diagnosed with a rare T cell lymphoma called Mycosis fungoides today. I wish I could adequately describe how many people I know with rare cancers at the moment.
My dad had a severe bout of COVID in March that caused hearing loss.
My dad had a severe bout of COVID in March that caused hearing loss.

“My dad had a severe bout of COVID in March that caused hearing loss.

It caused other health issues that resulted in organ failure and his death. His oncologist believes it hastened the spread of his cancer too (dormant for years). In his words, ‘COVID is a cancer accelerant.’”

·x.com·
My dad had a severe bout of COVID in March that caused hearing loss.